NasdaqGS:BRKRLife Sciences
Bruker (BRKR) Is Down 7.5% After Flat Q2 2025 Revenue Guidance - What's Changed
In the past week, Bruker Corporation released preliminary revenue guidance for the second quarter ended June 30, 2025, projecting revenue in the range of US$795 million to US$798 million, indicating reported sales are essentially unchanged year-over-year.
This early update offers insight into management's assessment of current market conditions and may signal shifts in demand dynamics across Bruker's core markets.
To assess how this flat quarterly revenue outlook factors into Bruker's...